Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1608390/000110465922088959/afmd-20220630x6k.htm
August 2023
June 2023
June 2023
May 2023
May 2023
April 2023
March 2023
December 2022
November 2022
November 2022
Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1608390/000110465922088959/afmd-20220630x6k.htm
Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Affimed N.V..
Affimed N.V.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 6-K Foreign Issuer Report
Material Contracts, Statements, Certifications & more
Affimed N.V. provided additional information to their SEC Filing as exhibits
Ticker: AFMD
CIK: 1608390
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001104659-22-088959
Submitted to the SEC: Thu Aug 11 2022 6:31:22 AM EST
Accepted by the SEC: Thu Aug 11 2022
Period: Thursday, June 30, 2022
Industry: Pharmaceutical Preparations